Introduction
Studying enveloped RNA virus assembly at the host cell surface is crucial for understanding the specificities and differences of the underlying molecular mechanisms. However, this requires tools to enable the nanoscale analysis of viral proteins at the single molecule level. For instance, human immunodeficiency virus type 1 (HIV-1) produces particles with a diameter of 100-130nm filled with 2000 Gag proteins. Recent progress in single-molecule localization microscopy allows deciphering protein organization and dynamics in a single cell at the nanoscale level (1, 2) . HIV-1 Gag polyprotein is the main determinant for HIV-1 particle assembly that occurs mainly at the plasma membrane of the host cell (3) . When expressed alone in a cell, HIV-1 Gag proteins can produce noninfectious virus-like particles (VLPs) that resemble viruses, but do not require maturation (encoded by the Pol gene) or envelope proteins (encode by the Env gene). Therefore, it is a very powerful tool for studying virus assembly in a minimal productive system (4) . Upon virus maturation, HIV-1 Gag polyprotein is cleaved by the viral protease into the following domains: Matrix protein p17 (MA), Capsid protein p24 (CA), Nucleocapsid protein p7 (NC) as well as p6 domain and two spacer peptides (sp1 and sp2). MA is myristoylated and contains a highly basic region involved in Gag targeting and anchoring to the inner leaflet of the plasma membrane of host cells where viral assembly occurs (reviewed in (5) (6) (7) . CA, via CA-CA interacting domains, promote Gag-Gag oligomerization in vitro (8, 9) and in cells (10) . Particularly, the WM mutation within CA strongly reduces Gag oligomerization and consequently virus assembly (8) . NC, sp2 and p6 are required for Gag assembly and particle budding. Specifically, NC recruits the genomic RNA, but can also interact with cellular RNAs, to favour Gag-Gag oligomerization on the RNA template, in vitro and in cells (reviewed in (11) and (12) ). NC is therefore involved in virus assembly (12) and (13) , whereas p6 recruits the ESCRT proteins required for membrane scission and particle release (14) . The sp1, at the end of the CA, acts as a molecular switch for VLP assembly (15) . The kinetics of GFP-labelled Gag assembly and VLP formation have been previously described in adherent HeLa cells by measuring the local increase in fluorescent intensity of single virions (16, 17) . In these cells, it was estimated that 5 to 6 minutes were required for Gag VLP assembly in the absence of genomic RNA (16) and about 20 minutes to complete 90% of Gag VLP assembly and budding (17) . Jouvenet et al. (18) also reported that HIV-1 Gag and a fluorescent tagged viral RNA assemble at the plasma membrane. Moreover, it was recently shown that HIV-1 Gag assembly at the plasma membrane takes place at sites where the viral RNA is located (19) . The viral Gag proteins appears to stabilize the viral RNA at the plasma membrane and between 1/10 and 1/3 of the viral RNA is packaged into nascent particles in 30 minutes (20) . These interactions between the viral genome and Gag enhance virus assembly (21) . It suggested that the viral genomic RNA encoding Gag acts as a catalyser for virus assembly but it did not assess quantitatively the effect of the viral genomic RNA on the spatio-temporal coordination of HIV-1 Gag assembly. In this study, we wanted to measure HIV-1 Gag proteins dynamic changes during its assembly D R A F T into a VLP, at the inner living cell surface, and to quantify the role of the different Gag domains, and of the viral RNA, upon VLP formation in the host CD4 T lymphocytes. To this aim, the photoactivable fluorescent tag mEOS2 was introduced into the HIV-1 Gag precursor (Gag(i)mEOS2). This tag allows using live photoactivated localization microscopy (PALM) (1, 22) . Indeed, live PALM provides a precise spatio-temporal description of VLP formation, at the surface of individual cells, with a spatial resolution of about 50 nanometres and temporal resolution in the millisecond range. By coupling live PALM, TIRF-microscopy, and statistical analyses based on millions of Gag protein localizations and hundreds of buds, we could monitor non-infectious immature HIV-1 VLP formation at the cell plasma membrane of CD4 T cells molecules after molecules. Moreover, by comparing wild type (WT) and assembly-defective Gag mutants, we could identify which Gag domains are crucial for Gag assembly coordination at the host T cell surface. First, we found that in fixed CD4 T cells, Gag assembly platforms are rarely formed at the cell surface when Gag C-terminal end is deleted (the portion that contains the NC-viral RNA interaction domain). Then, based on the temporal changes observed in localization density maps, we showed that Gag VLP assembly in T cells requires between 5 and 7 minutes and 15min total to complete budding. Finally, by combining live PALM Bayesian inference analysis of single protein dynamic interaction maps with a diffusion and effective energy trapping model (23, 24) , we quantified Gag trapping energy during assembly. Moreover, we analysed the temporal correlation between changes in the density and the trapping energy, ie Gag interaction, during VLP assembly and brought evidence that the cis-packageable viral genome that encodes Gag(i)mEOS2 spatio-temporally most probably coordinates VLP assembly at the cell surface of CD4 T lymphocytes.
Results
Expression of WT Gag(i)mEOS and assembly-defective mutants in Jurkat T cells. First, WT HIV-1 Gag(i)mEOS2 and known assembly defective mutants that harbour the mEOS2 tag were generated (Fig. 1a) . The tag was introduced between MA and CA, thus preserving Gag capacity to assemble and to bud from the cell membrane after transient expression in mammalian cells (25) . WT Gag(i)mEOS2 was produced using either the pNL4.3∆Pol∆Env plasmid that includes also a cis-Psi-signal on the viral RNA that promotes viral RNA packaging into the VLP (NL4.3∆Pol∆Env Gag, hereafter) (26) or the pGag-(i)mEOS2 WT plasmid without this signal (WT Gag, hereafter). The WM, MACASP1, MACASP1/WM and ∆dp6 Gag mutants were derived from WT Gag(i)mEOS2 (see Methods). WM harbours a mutation in CA that reduces CA-CA interactions and impairs Gag oligomerization. The MACASP1 mutant carries a stop codon at the end of CA-SP1 and therefore, lacks Gag C-terminus (NC-sp1-p6) (27) . In ∆p6, a deletion in the p6 domain of Gag impairs ES-CRT recruitment and consequently particle release (14) . Indeed, tethered ∆p6 particles remained attached to the cell membrane ( Supplementary Fig. S1a ), as previously reported (14) . All the Gag proteins were well expressed after transient transfection in Jurkat CD4 T lymphocytes, as indicated by western blot analysis (Fig. 1b) and by flow cytometry (Fig. 1e) . Cell viability analysis by flow cytometry indicated that 40-50% of cells were alive after electroporation (Fig. 1d) . Analysis of the geometric mean of fluorescent intensity (Fig. 1e) showed that 24 hours post-transfection, the global protein expression level was comparable for WT Gag and NL4.3∆Pol∆EnvGag, whereas it was 2-fold lower, on average, for MACASP1, WM and mEOS2 (vector alone). Finally, VLP production was assessed by semi-quantitative western blot analysis with an anti-CA antibody (Methods) (Fig. 1b and 1c) . Only purified WT Gag and WM VLPs could be easily observed, whereas MACASP1 VLPs were often undetectable (Fig. 1b) . In agreement, VLP release calculation showed that VLP production decreased from about 50% to 10% for MACASP1 (Fig. 1c) . The capacity of WT Gag and mutants to bind to cell membranes was checked with membrane flotation assays in HEK293T cells (as described in Thomas et al. (27) ) ( Supplementary Fig. S2a ). Although Gag was well expressed (Fig. 1b) , the fraction of WT Gag bound to cell membranes was between 60 to 80% of total Gag ( Supplementary Fig. S1b ), and this value further decreased for WM and MACASP1 (p<0.01), and even more for the WM/MACASP1 double mutant (p<0.001). This made impossible analysis of the later by live PALM. These results indicate that upon alteration of Gag multimerization capacity, Gag is less bound to cell membranes and confirm a role for Gag oligomerization in stabilizing Gag-membrane interactions, in agreement with (28) . Moreover, it was recently shown that in vitro Gag oligomerization occurs also on PIP2-containing lipid membranes and that it is reduced by the same WM mutation in the CA domain of Gag (9). Transmission electron microscopy was then used to check whether WT Gag(i)mEOS2 and mutants could form particles (Gag VLPs) (Supporting information). Upon expression of WT Gag, cells produced high amounts of electrondense budding vesicles (i.e., Gag VLPs). After transfection of NL4.3∆Pol∆Env Gag, particles seemed rarer at the cell surface than in WT Gag-expressing cells, possibly due to inefficient release. Quantification of the size of 40 to 150 particles ( Supplementary Fig. S1b ) indicated that the largest VLPs were produced in WM-expressing cells (205nm in diameter), whereas they were smaller (124nm in diameter on average) in WT Gag-expressing cells. Upon transfection of MACASP1, very rare VLPs were detected, often localized at the plasma membrane, as indicated by the dark staining at the cell membrane ( Supplementary Fig. S1a ). HEK293T cells can naturally produce some vesicles (mock) that are not electron-dense structures ( Supplementary Fig. S1a ). However, neither dark staining at the plasma membrane nor VLP was detected in mock cells (Supplementary Fig. S1a ). These results are in agreement with the literature and allowed us to select the HIV-1 Gag protein variants that were well expressed in Jurkat T cells and that could bind to cell membranes, two prerequisites for analysing Gag(i)mEOS2 assem-
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HIV-1 Gag mobility and assembly platform density are impaired at the Jurkat T cell surface upon deletion or mutation in Gag assembly domains. First, dynamics of single Gag molecules at the cell surface were analysed by reconstructing the trajectories from live PALM data acquired on CD4 Jurkat T cells in TIRF mode (Fig. 2a) . Using a simple diffusive model (Brownian motion), the instantaneous motion amplitudes were calculated by estimating the diffusion coefficient (D) from the mean square displacement (MSD) curve of each single-molecule trajectory. Although this measure is known to be noisy, the large number of short trajectories provided a valid estimate of the typical motion at the population scale. MSDs were computed for all trajectories longer than 8 frames obtained on the entire cell surface by single particle tracking PALM in 5-10 cells (see Methods). Then, all individual D values were pooled and their distribution was normalized and plotted on a logarithmic scale (Fig. 2b, open (Fig. 2b) were decomposed into different components using the D distributions of: i) CAAX(i)mEOS2 molecules anchored into the lipids of the T cell plasma membrane, to mimic the diffusion of Gag monomers at the beginning of the assembly, and ii) WT Gag(i)mEOS2 molecules irreversibly trapped in an already formed and released VLP, to mimic the diffusion at the assembly end (Fig. 2c) . The maximal D was 0.6±0.5 µm 2 .s −1 for CAAX(i)mEOS2, and (2±0.8).10 −3 µm 2 .s −1 for trapped WT Gag(i)mEOS2 into a VLP (Fig. 2c) . From this linear decomposition, an intermediate population could be extracted that was considered to represent the D distribution of Gag molecules in assembling platforms (green in Fig. 2b and d) . These data showed that the immobile fraction (blue in Fig. 2b and d) was comparable for WT and mutant Gag molecules, whereas the intermediate and mobile fractions (green and red, respectively, in Fig. 2b and 2d) varied. The proportion of highly mobile WT proteins at the cell surface was very low (11 to 19% of all Gag molecules), while mutations in Gag oligomerization domains (WM for CA-CA interactions and MACASP1 for NC-RNA interactions) strongly increased this fraction to 39% and 52%, respectively. Consequently, the intermediate Gag population decreased from 82-69% for WT proteins to 54% and 34% for the WM and MACASP1 mutants, respectively. Again, this indicates that deleting Gag C-terminal domains, including the NC and p6, leads to an increase of highly mobile Gag fractions at the cell surface. This result is in good agreement with data on the measurement of Gag∆NC mobility in HeLa cells (26, 29) . 
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WT purified VLPs Table 1 . Mean Diameter and surface density of the identified clusters in Jurkat T cells: Quantification of Gag assembly platform size and density at the cell surface of fixed Jurkat T lymphocytes for WT Gag and each mutant (WM, MACA, ∆p6), NL4.3∆Pol∆Env Gag (in the presence of the packageable Psi-RRE genomic RNA), and the mean apparent VLP diameter. *: As illustrated in Figure S1 , the ∆p6 mutant is generating clusters of VLPs or arrested budding particles, which are not possible to resolve individually in PALM microscopy. Consequently, the mean density measured here is underestimated, and the mean apparent diameter is overestimated. Fig. 3b shows their associated distributions of the Gag clusters mean diameters and their log-normal fit obtained from several cells. Only MACASP1 is not following this fit. As shown in table1, the mean apparent diameters of WT Gag (112±54 nm) and NL4.3∆Pol∆Env Gag (117±65nm) were not significantly different (see table S1 for statistics tests), but were significantly smaller than the WM one (121±56 nm). This was confirmed by electron microscopy ( figure S1 ). Due to the low number of observed MACASP1 clusters, their mean diameter could not be determined. Finally, these mean diameter values were all found to be significantly smaller than the VLP one (139±42 nm) obtained from images of purified VLPs produced by WT Gag-expressing Jurkat T cells ( Fig. 3a , WT purified VLPs), suggesting that theses clusters are Gag assembly platforms. The values obtained here are in agreement with previous PALM data on WT Gag assembly platform sizes described in adherent COS cells (1, 30) and suggests that the assembly platform size is independent of the host cell type. The PALM images were then used to quantify the platform density (i.e., the number of assembly platforms per cell surface units). It decreased from 4.5±1.7 for WT Gag and 3±1.2 clusters per µm 2 for NL4.3∆Pol∆Env Gag to 1.7±1.5 clusters per µm 2 for WM and to 0.05±0.01 for MACASP1 Gag mutants, suggesting that WM and MACASP1 increased mobility observed in Figure 2d partly reflects, at equilibrium, the decrease in assembling platform density observed at the CD4 T cell surface. Importantly, this result suggests a strong role of the Gag Cterminus domain (NC-sp2-p6) in assembly platform formation in CD4 T cells. Thus, PALM images of a Gag-∆p6 mutant ( Fig. 3a and b, ∆p6) , which displays only the deletion of the p6 domain at the C terminus of Gag, were acquired. ∆p6 mutant is a VLP release deficient mutant, forming grapes of VLPs (Inset of Fig. 3a and Supplementary Fig.S1a ). This lead to an overestimation of the clusters mean diameter and underestimation of their density (Table1). Nevertheless, cells expressing ∆p6 exhibited assembly platforms densities, and at least 20 times higher than the one observed for MACASP1 ( Table 1 ), revealing that the NC domain of Gag was the major determinant for high density Gag clusters at the surface of Jurkat T cells.
Quantifying the trapping energy experienced by single Gag molecules during VLP formation in living CD4
Jurkat T Cells. Since global analysis of Gag dynamics only partly reflected the properties of assembly, Live PALM was then used to monitor the changes in motion and densities of single Gag molecules in the vicinity of the assembling platforms. For that purpose, we created a movie with all the frames acquired in 26min. Each image of this movie included all the molecules localized in a 4min window with a sliding time of 10s. Figure 4a upper part shows two successive images of a such made movie of one forming VLP (WT Gag) exhibiting changes in molecular localization densities (LD) (see also figure S3 ). Figure 4a lower part show the associated trajectories of single WT Gag molecules around this forming VLP (see also video S1). In addition to diffusive motions, Gag trajectories directed towards the VLP centre were also observed, suggesting that VLPs in formation act as an energy trap for neighbouring Gag proteins. Therefore, Gag dynamics were analysed with the overdamped Langevin equation (suitable for heterogeneous diffusion processes) as an approximate model (Methods, eq. ). A newly developed approach using Bayesian inference was used to analyse our data (23) . Space was partitioned using a simple unsupervised approach and space domains were defined with the Voronoi tesselation. The estimators were the Maximum a Posteriori of the diffusion (D) and the effective trapping energy (E). Diffusion ( Fig. 4b ) and effective trapping energy (Fig. 4c ) maps were built from the motions of all tracked single Gag molecules. To monitor precisely VLP formation, the start time and the position of forming VLPs (assembling platforms, hereafter) were identified as the time and position where the LD was three times higher than in the surrounding area. Moreover, the apparent VLP radius was also measured and was defined as the distance were the LD was four times lower than at the VLP centre (see Methods). By multiplexing this approach, more than 600 assembling platforms could be analysed in four different cells for WT and mutant Gag proteins. Then, LD, D and E changes during the overall acquisition time were investigated (see video S2 for examples of temporal changes of D and E maps) and were plotted (Fig.  4 d,e,f) for each forming VLP. From these plots, the maximal LD increase (LDI, red arrow) and the duration of this increase (dotted red arrow) could be measured. This last value was considered to represent the VLP formation time. It was previously shown (17) that HIV-1 Gag assembly in adherent HeLa cells can be divided in three phases characterized, respectively, by an increase in LD, followed by a plateau value (e) Normalized distribution diagrams of the mean diffusion and the trapping energy (left), the mean diffusion and the localisation density increase (right) for each experimental condition, from CAAX(i)mEOS2 (no assembly) to WT Gag and NL4.3∆Pol∆Env Gag (highest assembly efficiency).
D R A F T
and then a decrease in LD (due to particle release). These three phases could also be observed here in the host CD4 T cells (Fig. 4d , Table S2 ). The mean diffusion (bold dotted line in Fig. 4e , Methods, eq. 9) and the maximum trapping energy (∆E, full red arrow in Fig. 4f , Methods, eq. 10) could also be extracted, as well as the duration of the trapping energy increase (dotted red arrow in Fig. 4f ). As Gag selfassembly seemed to locally modify the mobility behaviour of the surrounding Gag molecules, first, diagrams of the normalized distributions of the ∆E and D values for WT Gag and mutants as well as for CAAX(i)mEos2 (negative control for assembly) were generated for all 600 assembly platforms identified in section 3 (Fig. 4g) . These diagrams showed that the normalized distribution peaks were progressively drifting from the right for CAAX(i)mEos2 (non-assembling molecules) to the left for NL4.3∆Pol∆Env Gag (assembling Gag molecules), i.e., from high to low diffusivity. Moreover, WM molecules formed two populations characterized by a distribution similar to that of MACASP1 and WT molecules, respectively. Importantly, while the Gag mutants had spread distributions, NL4.3∆Pol∆Env Gag always exhibited a quite narrow and fairly centred peak. In parallel, the D/LDI diagram show that increasing LDI lead to decreasing D, supporting the usefulness of these 3 parameters to quantitatively describe the assembly process. Surprisingly, the mean ∆E values (1-2 kbT independently of the condition) ( Fig. 4g) were not in favour of an attractive process during assembly. However, they were the mean of all "on-going" assembling VLPs, including those that will assemble imperfectly, i.e. not reaching the fully assembled VLP state. Indeed, the total density (i.e., LD sum over the acquisition time) should reach the maximum when VLPs are fully assembled, whereas the maximal LDI could be explained by different situations (see figure 5a for a schematic representation). For example, an assembly platform not leading to VLP formation can have a high LDI value, but a low total density (e.g., MACASP1 in Fig. 5b ). Conversely, a VLP almost fully assembled suddenly appearing in the field of view will have a low LDI, but a high total density. To discriminate amongst these different possibilities, the LDI values were distributed as a function of the total density of every identified assembling platform (n >600) for each mutant (Fig. 5b) . Finally, to monitor correctly the formation of single VLPs in T cells, only isolated assembling platforms (i.e., separated by 400 nm, which is about seven times the radius of a released VLP) were considered. We therefore explored threshold values for each parameter (LDI and total density value) in order to be in line with the relative assembling platforms densities observed in fixed cells (Fig. 2, table 1 ) and the VLP production (Fig. 1c) . Particles with high LDI (>2,500 µm −2 ) and total density values >20,000 µm −2 were selected (red lines on fig 5b) since only two of the 600 MACASP1 clusters identified were above these threshold values. Conversely, these thresholds allowed selecting 91 assembly platforms for NL4.3∆Pol∆Env Gag, 76 for WT Gag and 36 for WM. The reduction by half of the number of assembly platforms for WM compared with WT Gag is in agreement with their VLP release data (Fig. 1c) and cellular densities (Table 1) . First, we analysed the distribution of the VLP formation time values (Fig. 5c) The results indicated that the mean time was not significantly different for WT Gag, NL4.3∆Pol∆Env Gag and WM (1160±350s, 1020±370s and 1003±350s, respectively). However, the individual values were very variable (from 350s to 1800s). Calculation of the duration of the first two phases (i.e., LD increase and plateau) showed that the first phase (assembly) lasted about 5min for NL43∆Env∆Pol Gag, 7 min for WT Gag and 6min for WM. The plateau phase duration was about 6 min for all three Gag variants (the exact values are in Supplementary Table 1 ). Altogether these results suggest that: i) MACASP1 forms low-density assembling platforms that mainly do not reach the VLP formation stage, ii) only WM and WT Gag can form high-density assembly platforms that lead to VLP formation, iii) on average, the time needed to make a VLP seems not affected by the presence of a packageable viral RNA or by CA-CA interactions. Then, we quantified the effective trapping energy for the VLP releasing assembly platform (Fig. 5d ). The only two selected MACASP1 particles exhibited no difference in effective trapping energy values compared with the total pool shown in Fig. 5d (∆E=1.5 ± 0.1 k b T ), whereas, the maximal effective trapping energy value slightly increased for the subset of VLP generated by WM (∆E=2.1 ± 1.2 k b T ) compared with the total pool. Conversely, the effective trapping energy value was strongly increased for WT Gag (∆E = 3.7 ± 1.6 k b T ) and NL4.3∆Pol∆Env (∆E = 3.7 ± 2.1 k b T ) compared with WM (p<5.10 −5 , Student's t test). These data indicate that a lack of correct CA-CA interactions during assembly induced a decrease of 40% in effective Gag trapping energy, ie Gag interaction, whereas the loss of NC abolished the existence of a trapping energy. Interestingly, the presence of the packageable viral RNA, or a Gag optimized codon sequence, did not influence the mean effective trapping energy value questioning the viral RNA assembly catalyser role. Indeed, molecular self-assemblies are more efficient when triggered by heterogeneous seeds (31-33), ie. Gag(NC)-RNA interaction could here act as the necessary seeds for controlling Gag self-assembly. To test this hypothesis, the time to reach the maximum LDI was compared to the time to reach the maximal effective Gag trapping energy intensity during the VLP assembly, for WM, WT Gag and NL4.3∆Pol∆Env Gag. Interestingly, differences in time were dispersed both for WM and WT Gag, whereas NL4.3∆Pol∆Env Gag showed one major peak centred on 0 (Fig. 5e ). This important result shows that most probably the presence of the packageable Psi-containing viral RNA genome, containing a wild-type Gag Rev-dependent coding sequence, acts as a seed that favour the temporal and spatial coordination of viral Gag particle assembly at the host CD4 T cell plasma membrane.
Discussion
In the last ten years, many efforts have been made to study the assembly of HIV-1 Gag particles in living cells (16) (17) (18) (19) 34 
D R A F T
imaging and advanced big data quantitative analyses, , and we thus highlighted the role of CA protein-CA protein and NC protein-RNA interactions using different known Gag assembly defective mutants. Analysis of the effects of different Gag mutations on viral assembly platform formation at the cell surface of Jurkat T cells showed that the assembly platform size was on average bigger for CA(WM) mutant compared to WT Gag. Assembly platform densities were also quite different among the Gag proteins tested, reflecting their efficacy in binding to or assembling at the cell membrane ( Fig.S2 and 2 ). MACASP1 molecules showed the most drastic assembly platform density reduction (by 50-fold compared with WT Gag) while WM exhibited only a 3-fold reduction. This suggests that the assembly efficiency at the T cell membrane strongly depends on Gag C-terminal domains (NC-sp2-p6), but not on the CA-SP1 interface alone. This is in good agreement with the work of Robinson et al. (35) , showing that a MACA mutant is unable to produce high order multimers of Gag using velocity sedimentation and gradient assays. Furthermore, the 20-fold higher density for ∆p6 compared with MACASP1 suggests that a direct effect of ES-CRT protein (such as Tsg101-p6 interaction) on assembly platform formation is unlikely. In addition, VLP formation analysis (videos S3 and S2 for ∆p6 and WT Gag, respectively) showed that ∆p6 Gag molecules can assemble, but accumulate in the same location. ∆p6 Gag signal persistence might indicate a defect in particle release, compared with WT Gag (as it can be visualized by electron microscopy in (14) and confirmed here for ∆p6 Gag(i)mEOS2 (see Fig S1) ). We thus propose that the remaining NC domain is the main determinant for Gag assembly platform formation at the surface of Jurkat T cells, most probably by a trapping of the Gag molecules via NC-RNA interactions that induce Gag-Gag multimerization. To go further, we performed live PALM and quantify single-molecule dynamics by analysing the trajectories of individual Gag molecules. We first characterized the motion of individual molecules using a simple Brownian diffusion approach. By analysing tens of thousands trajectories, extracting and decomposing their diffusion coefficients distribution, we detected that the proportion of assembling molecules was the highest for WT Gag and NL4.3∆Pol∆Env Gag in Jurkat T cells. Conversely, for oligomerizationdeficient mutants (WM and particularly MACASP1), the proportion of highly mobile, non-assembling molecules was the highest. This confirms that, these two mutants are less engaged in platform formation at the surface of Jurkat T cell plasma membrane. Hendrix et al. also observed an increase of the mobile fraction of oligomerization-deficient mutants in the cytosol (29) . Although we performed live PALM with TIRF illumination, we cannot exclude that a cytosolic fraction of Gag molecules linked to RNA might contribute to the measured diffusion coefficients. Nevertheless, in this case, we would also expect to observe the fast diffusing cytosolic component of RNA-attached WT Gag (D=2.8±0.5 µm 2 .s −1 ) described by Hendrix et al. (29) . Our D distributions show that this component is poorly present, suggesting that the observed Gag oligomerizing fraction was mainly located at the plasma membrane of Jurkat T cells. Then, we used quantitative live PALM on Gag(i)mEOS2 proteins in Jurkat T-cells to monitor their spatial density increase over time and to decipher the kinetics of viral particle formation. We observed three different phases in the formation and release of newly formed particles, as previously described in adherent HeLa cancer cell lines by TIRF microscopy. By live PALM in TIRF configuration, we found for WT Gag and NL4.3∆Pol∆Env Gag, that the first phase (considered as the assembly phase) lasted approximately 5min, in agreement with the value found by Jouvenet et al. (16) (36)) lasted approximately 10min, as observed in Hela cells (17) . We did not quantify the third phase because it was quite variable, possibly due to many different processes (pinching off, bleaching. . . ), but instead measured the total time of particle formation as the time length between the appearance and disappearance (i.e., return to the initial LD) of an assembly platform (see video S1). The mean duration was observed between 17min (for NL4.3∆Pol∆Env) and 20min (for WT Gag), but with high variability (7 to 30min), as already observed in HeLa cells (36) . This shows that the presence of the viral RNA does not significantly decrease the total assembly and release time of the virus like particle. Moreover, our and previous results (17, 36) , show that assembly duration and the time needed to achieve a fully released particle seem to be independent of the cell type. While visualizing individual Gag molecule tracks, we could observe that WT Gag(i)mEOS2 proteins tended to move towards the centre of assembling particles, suggesting the existence of an attractive potential. However, this could be an artefact due to the high molecule density in the platforms, leading to systematic reconnections with the molecules moving in their proximity (37) . As full trajectories were not required for VLP mapping, image to image graph matching was used to generate the most probable protein displacements (38) . The live PALM data were then analysed using Bayesian inference and the modified Langevin equation to quantify the motion of individual Gag molecules (23, 24, 39) . Using the Langevin description of the motion, the key dynamical properties were approximate as diffusion and effective energy maps, providing us with a more general understanding of the modifications of protein dynamics at the vicinity of assembling platforms. Therefore, by computing temporal maps of the diffusion and energy properties in and around the assembling platforms, we could measure the intensity and the spatial range of this attracting energy. We obtained the highest intensity for NL4.3∆Pol∆Env Gag and WT Gag (< ∆E >∼ 4k b T ). This value was almost half for the CA-CA(WM) mutant molecules that still generate platforms and was down to 1.5 k b T for MACASP1 molecules that do not generate VLPs. This last value is close to the thermal fluctuation energy (1k b T ) and therefore, typical of an energy that induced no Gag trapping. Recently, using coarse grained molecular simulation Pak et al. (40) has estimated that the oligomerization via CA-CA
hexamer formation due to SP1 interactions in the presence of (simulated) membrane and RNA could occur for weak SP1-SP1 interaction energy (∼4 k b T ). Interestingly, this value is exactly in line to what we find in Jurkat T-cells in the case of WT Gag. Nevertheless, the SP1-SP1 interaction defective mutant (WM) still generates virus like particules in CD4 T-cells although exhibiting a < ∆E > value lower than 4k b T . Moreover, the long spatial range ( 200nm, i.e., 1.5 bud diameter) observed here of the attractive forces apparently generated by assembly, suggest that this mean effective Gag trapping energy field cannot only be due to direct protein/protein or protein/RNA molecular interactions. On the opposite, membrane curvature-mediated interactions and forces exerted by each protein on the cell membrane could account for the energy fields observed here. Sens et al. (41, 42) theoretically predicted for caveolae that, when the force exerted on the plasma membrane by oligomers decreases, the resulting bud radius is proportionally increased. In our study, the almost two-fold reduced attractive energy for WM (reduced SP1-SP1 interactions) was correlated with the almost two-fold increase in the VLP diameter observed by electronic microscopy (Fig. S1 ). Results obtained here suggested that in Jurkat T-cells, the plasma membrane can then rescue the lack in efficient CA-CA dimerization in order to produce immature particles, as already observed on model membranes (9) . This is also in good agreement with the labile membrane bound form of WM Gag mutant observed in 293T HEK cells in the Robinson et al. (35) biochemical and EM study. Finally, nor the presence of the assembly-triggering Psi RNA sequence, neither the Rev/RRE driven RNA trafficking or codon optimized Gag sequence, did change the attraction energy intensity. Therefore, to gain more insights into the role of CMV-driven codon optimized Gag (WT Gag and WM) versus the cis packageable Rev/RRE driven viral Psi containing RNA genome (NL4.3∆Pol∆Env Gag), we analysed the temporal correlation between Gag density and the Gag attraction energy increase. Unlike WT Gag and WM, a perfect temporal correlation between Gag density and Gag trapping energy was observed for NL4.3∆Pol∆Env Gag. This result reveals an important role for the Psi/RRE containing viral RNA genome in the spatio-temporal coordination of HIV-1 Gag assembly at the plasma membrane of CD4 T cells. It could be due either by contributing to the specific interaction of the genomic RNA with the NC domain of Gag during Gag multimerization at the cell membrane, or by the fact that a Rev/RRE genomic RNA intracellular trafficking and location will contribute to coordinate virion assembly. This latter hypothesis goes with the recent work of Becker and Sherer showing that the viral mRNA subcellular trafficking and location regulates viral assembly at the cell membrane (19) . The first hypothesis is in good agreement with the previous finding (43, 44) that the viral RNA genome (containing the Psi signal for encapsidation) acts as a structural element for retroviral particles, and with the model recently proposed by Chen et al. (26) showing that miRNA binding to Gag NC inhibits HIV-1 assembly. This goes with reports showing that high-order Gag multimerization only occurs at the cell mem- brane (45) and is dependent on Gag membrane-binding capacity. Conversely, low-order Gag multimers bind to viral genomic RNA in the cytosol prior to assembly and would be dependent on the NC domain of Gag (29, 35, 45) . Here, our results suggest that the formation of high-order Gag multimers occurring at the plasma membrane of CD4 T cells depends strongly on NC.
In conclusion, using quantitative single molecule microscopy, we could measure the evolution of the trapping energy occuring during Gag self-assembly at the CD4 T cell plasma membrane (see figure 6 for a schematic illustration).
We were able to show, for the first time, that the presence of a packageable cis-acting viral RNA genome, coding for Gag, revealed a spatio-temporal coordination of HIV-1 assembly at the CD4 T cell plasma membrane. This strongly suggests that the faith of the viral RNA genome (trafficking or encapsidation) is synchronizing Gag assembly at the cell membrane.
Methods
Cell culture. Jurkat T cells (a human T-cell leukaemia cell line) were grown in RPMI 1640 plus Glutamax (Gibco) supplemented with 10% foetal calf serum (FCS) and antibiotics (penicillin-streptomycin. Human embryonic kidney (HEK) 293T cells were grown in DMEM (Gibco) supplemented with 10% FCS and antibiotics (penicillin-streptomycin).
DNA plasmids. The plasmid expressing HIV-1 Gag with the internal (located between MA and CA) mEOS2 tag fused with the Gag protein was called pGag(i)mEOS2 WT (CMV promoter-driven codon optimized Gag sequence), and used to generate the WM and MACASP1 mutants by site-directed mutagenesis. Another plasmid that expresses HIV-1 WT Gag(i)mEOS2 and the viral cis-packageable Psi RNA genome with a Rev/RRE dependent Gag coding sequence (pNL4.3∆Pol∆Env) was kindly provided by Dr Eric Freed (NIH, Frederick, MD, USA), and was described previously (26) .
Site-directed mutagenesis. Mutations were introduced in pGag(i)mEOS2 WT by site-directed mutagenesis using the QuickChange mutagenesis kit (Agilent) according to the manufacturer's protocol. Tryptophan 184 and methionine 185 were replaced by two alanine residues (WM mutant, as in (29)) using the primer 5'-GAC GTG AAG AAC GCA GCT ACC GAG ACC CTG-3'. NC-sp2-p6 were deleted by inserting a stop codon after the sp1 sequence (MACASP1 mutant) using the primer 5'-GCG ACC ATC ATG TAG CAG CGC GGC AAC-3'. The p6 sequence was deleted by inserting a stop codon after the sp2 sequence (∆p6 mutant) using the primer 5'-CCC GGC AAC TTC TAG CAG AGC CGC CCC-3'. All plasmids were amplified in E. coli and mutations were confirmed by DNA sequencing (MWG Eurofins).
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DNA transfection. Jurkat T cells (2x106) were microporated with 4µg of each plasmid using the Amaxa system (Lonza) and then plated in RMPI complete medium and harvested 24h post-transfection, as described in (27) . HEK293T cells were transfected by using the calcium phosphate buffer, as described in (46) .
Cell viability, transfection efficiency and protein expression by FACS. Cell viability, cell transfection and protein expression were assessed with a BD FACS Calibur flow cytometer. FACS results were analysed with the FlowJo software v10. The cell viability rate was calculated as the ratio of cell size and granulometry over the total cell number. Protein expression rates were monitored using the geometric mean of the mEOS2(+) cell fluorescence intensity distribution. Antibodies. Western blots were performed using the anti-CAp24 (NIH AIDS Reagent Program HIV-1 p24Gag monoclonal (24-4) mouse antisera) and mouse anti-LAMP2 (human lysosomeassociated membrane protein 2) (H4B4) (Santa Cruz Biotechnologies) antibodies, followed by anti-mouse and anti-rabbit antibodies coupled to horseradish peroxidase (HRP) (Dako), and an anti-GAPDH HRP-coupled antibody (Abcam).
VLP purification and immunoblotting. To monitor viral particle production, cell culture media containing VLPs were harvested at 24h posttransfection. Jurkat T cell supernatant was clarified by centrifugation at 60xg for 10min, while HEK293T cell supernatants were filtered (0.45 µm pore size 
where I V S is the viral supernatant (quantification of the immunoblot signals for Gagp55 and CAp24); I CE is the quantification of the Gagp55 signal in cell extracts; and I blank is the background signal. GAPDH served as loading control.
Photo Activation Localization Microscopy.
Sample Preparation. To increase cell adhesion, Jurkat T cells were seeded on poly-lysine-coated coverslips and left in culture medium at 37°C, 5% CO2 for 30 min. After rinsing with PBS, cells were incubated at 37°C in microscopy buffer (MB) (150mM NaCl, 20mM HEPES pH7.4, 1mM CaCl2, 5mM KCl, 1mM MgCl2 pH 7.4 and 100 nm TetraSpeck™ microspheres) for live PALM experiments, or fixed with 3% PFA in PBS at room temperature for 15min for PALM experiments. In this case, after fixation, cells were rinsed with 50mM NH4Cl for 5min and then several times with PBS before transfer in MB for microscopy analysis.
Live PALM and PALM image acquisition. Cells were imaged at 37°C in Ludin chambers (Life Imaging Services) with an inverted motorized microscope (Nikon Ti) equipped with a 100x 1.45 NA PL-APO objective and a perfect focus system for long acquisition under TIRF illumination. For live PALM, cells that express mEOS2-tagged Gag molecules were photoactivated using a 405nm laser (Omicron) and the resulting photoconverted single-molecule fluorescence was excited with a 561nm laser (Cobolt Jive™). Both lasers illuminated the sample simultaneously. The photoactivation laser power was adjusted to keep the number of the stochastically activated molecules constant and sparsely distributed during the acquisition to allow single-molecule localization (46) . Fluorescence signals were collected by using a dichroic and an emission filter (F38-561 and F39-617, respectively, Semrock) and a sensitive EMCCD camera (Evolve, Photometric). Acquisition was guided by the MetaMorph software (Molecular Devices) at 50Hz in streaming mode and analysed online with laser feedback to ensure the optimal and constant number of localizations during acquisition (46) . Multicolour fluorescent 100nm TetraSpeck™ microspheres (Invitrogen) were used as fiduciary markers to acquire and correct for lateral drifts occurring during long-term acquisitions.
Single-molecule acquisition and tracking. LivePALM experiments allowed the acquisition of sets of 80,000 images per cell that were analysed with WaveTracer (Molecular Devices) and the custom-made PALM Tracer analysis software to extract molecule localization and dynamics data. Fluorescent single molecules were localized and tracked over time using a combination of wavelet segmentation and simulated annealing algorithms (47) , (48) operating as a plug-in for the MetaMorph software (Molecular Devices). Using the same experimental conditions described above, the system resolution was quantified to 46 nm at full width and half maximum using fixed mEOS2-expressing cells. 200 two-dimensional distributions of singlemolecule positions belonging to long trajectories (>30 frames) were analysed by bi-dimensional Gaussian fitting. The resolution was defined as 2.3 σxy, where σxy was the standard deviation of the Gaussian fit. Trajectories equal or longer than 10 points were analysed using the mean squared displacement MSD computed as
where x i and y i were the coordinates of the label position at the time i∆t. The diffusion coefficient D was defined as the slope of the affine regression line fitted from the MSD(n∆ t) with 0 < n < 5 . The log distribution of D experimental values was linearly decomposed by the log distribution of VLP and CAAX(i)mEOS2 using the following equation:
where R D was the residual, E D the experimental distribution, and a and b the proportions of VLP and CAAX distributions in each experimental distribution. D 1 , D 2 D 3 and D 4 were respectively set to: 10 −5 , mean VLP value (2.10 −3 ), mean CAAX value (0.6), 20 µm 2 .s −1 . Assembling platform apparent diameter were determined as the 1/e 2 diameter of a bi-dimensional Gaussian fitting.
Robust statistical Gag dynamics analysis using Bayesian inference.
The large amount of data and the time-evolving nature of the process required an automated and stereotypical way to treat data. Thus, all data were treated exactly in the same manner, including the inference hyperparameters. A pipeline was designed for all data analysis. The pipeline included five steps:
• Single Molecule Localization Single Molecule Localization was implemented in MATLAB using the slightly modified MTT algorithm (49) . To limit errors due to tracking algorithms, we did not track single molecules, but used optimal assignments between consecutive images to extract Gag movements. This procedure is detailed in Supplementary Note ??. Region of interest (ROI) selection was then based on LDs (localisation densities). ROIs were selected as squared areas of 2 µm in length centred on the maximum of density. The number of ROIs per cell was limited to 30. In each ROI, the effective centre of a VLP, r ef f , was defined as the point with the highest LD (ρ tot max ) (cumulated on the 80 000 frames). The effective radius, R ef f , of a VLP was defined as the average distance between r ef f and the points of a density equal to (ρ tot max /4). In the analysis, points within R ef f were considered to be in the VLP. Depending on the density of maturing VLPs, more than one VLP D R A F T
